Skip to content

T-piece Versus Pressure-support for the Spontaneous Breathing Trial

T-piece Versus Pressure-support for the Spontaneous Breathing Trial Before Extubation in Patients at High-risk of Reintubation: a Multicenter Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04227639
Acronym
TiP-Ex
Enrollment
1000
Registered
2020-01-13
Start date
2020-01-31
Completion date
2021-09-07
Last updated
2022-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extubation, Weaning From Mechanical Ventilation

Brief summary

The main objective will be to compare the number of ventilator-free days within the 28 days following the first spontaneous breathing trial between strategies of extubation performing spontaneous breathing trials with T-piece trials or with Pressure-Support trials. To do that, the study director proposed to conduct a prospective multicenter randomized controlled open-label trial comparing these 2 strategies of weaning in patients at high-risk of extubation failure in the Intensive Care Unit. Patients included will be randomized before performing the first spontaneous breathing trial and will be assigned to one of the following two groups according to the weaning strategy: T-piece trial group or Pressure-Support trial group.

Interventions

PROCEDURET-piece trial

T-piece trial will be performed for around 1 hour with a T-piece connected to the extremity of the endotracheal tube by simply disconnecting the patient from the ventilator and by providing additional oxygen (≤ 6 L/min)

PROCEDUREPressure-support trial

Pressure-Support trial will be performed for around 1 hour without disconnecting the patient from the ventilator, by using a low level of pressure-support (PS 8 cm H2O) with a FiO2 ≤ 40% and without positive end-expiratory pressure (PEEP), while continuously monitoring the respiratory rate and tidal volume on the ventilator display.

Sponsors

Poitiers University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Duration of mechanical ventilation prior to the first spontaneous brathing trial \> 24h 2. Patients at high-risk of reintubation according to the following criteria: Patients older than 65 years, or those having any underlying chronic cardiac or lung disease. 3. Patient meeting all weaning criteria according to the international conference consensus on weaning. * Respiratory rate ≤ 35 breaths per minute, * Adequate oxygenation defined as SpO2 \> 90% with FiO2 ≤ 0.4 or PaO2/FiO2 \> 150 mm Hg with positive end-expiratory pressure (PEEP) ≤ 8 cmH2O, * Adequate cough, * Patient awake with a Richmond Agitation-Sedation Scale between +1 and -2 * No continuous sedation, * Hemodynamic stability with no need for vasopressors (or minimal dosis). 4. Informed consent given by the relatives or the patient himself.

Exclusion criteria

1. Patients admitted for traumatic brain injury 2. Pre-existing peripheral neuromuscular disease (underlying myopathy or myasthenia gravis) 3. Do-not-reintubate order at time of the first spontaneous breathing trial 4. Patient previously included in the study 5. No Health insurance coverage 6. People under protection: Pregnant or breastfeeding women, minor patients, subjects with guardianship or under law protection. 7. Refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Number of ventilator-free days at day 28Day 28The number of ventilator-free days at day 28, defined as the number of days alive and without invasive mechanical ventilation (intubation or tracheostomy) between the first spontaneous breathing trial (day 1) and day 28.

Secondary

MeasureTime frame
The number of patients extubated within the 72 hours and within the 7 days following the first spontaneous breathing trial.Hour 72, Day 7
The number of patients extubated after simple (24h), difficult (> 24 hours and ≤ 7 days) or prolonged ( > 7 days) weaningDay 28
The number of patients extubated after the first spontaneous breathing trial and not reintubated within the following 72 hours.Hour 72
The number of days between the first spontaneous breathing trial and the first extubation attempt among extubated patientsDay 28
The number of days alive and without mechanical ventilation (including intubation or non-invasive ventilation) between the first spontaneous breathing trial (day 1) and day 28.Between Day 1 and Day 28
The number of patients with post-extubation respiratory failure within the 7 days following extubation.Day 28
Length of stay in ICU in days.Day 90
Numbers of patients died in ICU, at day 28 and at day 90.Day 28 and Day 90
The number of patients reintubated within the 72 hours and within the 7 days following extubation.Day 28

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026